{ "ok": true, "cik": "49071", "ticker": "HUM", "name": "HUMANA INC", "filings": [ { "form": "8-K", "filed": "2026-09-01", "items": [ "7.01 Regulation FD Disclosure" ], "url": "https://www.sec.gov/Archives/edgar/data/49071/000004907126000052/0000049071-26-000052-index.htm" }, { "form": "10-Q", "filed": "2026-07-29", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/49071/000004907126000050/0000049071-26-000050-index.htm" }, { "form": "8-K", "filed": "2026-07-29", "items": [ "5.02 Departure or Election of Directors; Appointment of Officers", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/49071/000004907126000047/0000049071-26-000047-index.htm" }, { "form": "8-K", "filed": "2026-07-29", "items": [ "2.02 Results of Operations and Financial Condition", "7.01 Regulation FD Disclosure", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/49071/000004907126000045/0000049071-26-000045-index.htm" }, { "form": "8-K", "filed": "2026-06-01", "items": [ "7.01 Regulation FD Disclosure" ], "url": "https://www.sec.gov/Archives/edgar/data/49071/000004907126000027/0000049071-26-000027-index.htm" }, { "form": "8-K", "filed": "2026-05-19", "items": [ "1.01 Entry into a Material Definitive Agreement", "2.03 Creation of a Direct Financial Obligation", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/49071/000004907126000025/0000049071-26-000025-index.htm" } ], "events12m": 15, "healthWatch": { "window": "last 12 months", "since": "2025-09-26", "signals": [ { "code": "5.02", "label": "Director or officer change", "count": 3, "latest": { "filed": "2026-07-29", "url": "https://www.sec.gov/Archives/edgar/data/49071/000004907126000047/0000049071-26-000047-index.htm" } } ], "note": "Events the company itself filed with the SEC, most serious first. Shown beside the figures; they do not change the range or its receipt." }, "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000049071.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=49071" }, "license": "Figures as filed with the SEC. Card text CC BY 4.0, POPS4.", "notAdvice": "Reporting, not investment advice. No price targets and no trading recommendations.", "edgar": "🫧 Edgar looked up HUMANA INC ($HUM). Last filing: 8-K (7.01 Regulation FD Disclosure), 2026-09-01. 15 event filings (8-K) in the past twelve months.", "auditor": { "changes": [], "nonReliance": [], "restatedSince": null }, "metrics": { "fiscalYearEnd": "2025-12-31", "revenue": 129664000000, "revenueGrowth1y": 0.10107760633826146, "revenueGrowthPerYear": 0.11776792596357621, "yearsOfData": 5, "operatingMargin": 0.02085389930898322, "operatingMarginPrior": 0.021755929382393152, "netMargin": 0.009277825765054294, "operatingCashFlow": 921000000, "capitalSpending": 546000000, "freeCashFlow": 375000000, "researchAndDevelopment": null, "researchShareOfRevenue": null, "cash": 4200000000, "longTermDebt": 12369000000, "longTermDebtChange": 0.10992462311557794, "revenueHistory": [ { "fiscalYearEnd": "2021-12-31", "revenue": 83064000000 }, { "fiscalYearEnd": "2022-12-31", "revenue": 92870000000 }, { "fiscalYearEnd": "2023-12-31", "revenue": 106374000000 }, { "fiscalYearEnd": "2024-12-31", "revenue": 117761000000 }, { "fiscalYearEnd": "2025-12-31", "revenue": 129664000000 } ], "totalEquity": 17657000000, "totalAssets": 48909000000, "equityRatio": 0.36101739966059415, "returnOnEquity": 0.06813161918785751, "dividendsPaid": 430000000, "payoutRatio": 0.3574397339983375, "dividendPerShare": 3.54, "dividendYearsRising": 0, "dividendCut": false, "priceBased": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown.", "earningsPerShare": 9.87, "sharesOutstanding": 120826000, "bookValuePerShare": 146.13576548093954, "revenuePerShare": 1073.1465082018772, "range80": { "low": 130290414003.33215, "high": 148739962564.69647, "baseline": 143846022095.73215, "n": 1471, "band": "b10", "bandLabel": "$10B+", "method": "v4.1", "credibility": 0.5, "growthYears": 4, "ownVolatility": 0.01747334717722121, "classVolatility": 0.06659579566308972, "volatility": 0.048684278065797094 }, "ifPaceHeld": { "low": 130290414003.33215, "high": 148739962564.69647 } }, "edgarette": "🔖 Exposure: revenue $129.7B (FY2025), total debt $12.4B. Experience: revenue up 10.1% on the year, up 11.8% a year over 4 years; operating margin 2.1%, down from 2.2%. Soundness: equity 36.1% of assets, return on equity 6.8%, payout 35.7% of profit. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $130.3B and $148.7B next year (method v4.1: its own 4-year record of growth weighed at 50% against $10B+ filers; on a year the method never saw, 83.4% landed inside). In a shock year the stress range is $122.9B to $156.8B. A statistical range, not company guidance. Against peers (10 filers, $50M+ revenue, hospital & medical service plans): operating margin 2.1% against a 1.3% median; growth 10.1% against 12.2%.", "peers": { "sic": 6324, "sicDescription": "Hospital & Medical Service Plans", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "6324", "growth": [ 0.1222, 10 ], "opMargin": [ 0.0134, 10 ], "equityRatio": [ 0.2641, 9 ], "returnOnEquity": [ 0.0506, 9 ] }, "summary": "Humana (HUM) grew revenue 10.1% in FY2025 to $129.7 billion, operating margin 2.1% against a 1.3% median for hospital & medical service plans, equity 36.1% of assets. Every figure is from the company’s own annual report filed with the SEC.", "chart": "
HUMANA INC against its own record and its peers
Operating marginPeer median 1.3%2.1%Revenue, on the yearPeer median 12.2%10.1%Equity of assetsPeer median 26.4%36.1%Return on equityPeer median 5.1%6.8%Payout of profit35.7%Gold tick: the median of 9–9 peers with $50M+ revenue in hospital & medical service plans
", "chartHorizon": "
Handed back now, or kept to compound
Of each dollar of profit35.7% paid out64.3% keptHanded back per share$3.54Growth its own profit can fund4.4%retained x return on equityRevenue growth it managed10.1%last year, for comparison

Gold is paid out to shareholders; navy is kept in the business. Retained profit times return on equity is the pace a company can fund from itself. Facts from the filings, not a recommendation.

", "backtest": { "tests": 15, "hits": 11, "rate": 0.7333333333333333, "method": "v4", "byYear": { "2011": [ 1, 1 ], "2012": [ 1, 1 ], "2013": [ 1, 1 ], "2014": [ 0, 1 ], "2015": [ 1, 1 ], "2016": [ 0, 1 ], "2017": [ 1, 1 ], "2018": [ 1, 1 ], "2019": [ 0, 1 ], "2020": [ 0, 1 ], "2021": [ 1, 1 ], "2022": [ 1, 1 ], "2023": [ 1, 1 ], "2024": [ 1, 1 ], "2025": [ 1, 1 ] }, "note": "hindsight: the same credibility-weighted range on the company's own past years. Years 2018-2023 were used to fit or tune the method, so only 2025 outcomes are fully out of sample." }, "registry": { "logged": "2026-09-26T16:33:40.867Z", "hash": "0b4576feb331bea6", "status": "open" }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "schema": "pops4.edgarette.card/1", "card": { "summary": "Humana (HUM) grew revenue 10.1% in FY2025 to $129.7 billion, operating margin 2.1% against a 1.3% median for hospital & medical service plans, equity 36.1% of assets. Every figure is from the company’s own annual report filed with the SEC.", "exposure": { "fiscalYearEnd": "2025-12-31", "revenue": 129664000000, "totalDebt": 12369000000, "cash": 4200000000 }, "experience": { "revenueGrowth1y": 0.10107760633826146, "revenueGrowthPerYear": 0.11776792596357621, "operatingMargin": 0.02085389930898322, "operatingMarginPrior": 0.021755929382393152, "netMargin": 0.009277825765054294, "freeCashFlow": 375000000 }, "soundness": { "equityRatio": 0.36101739966059415, "returnOnEquity": 0.06813161918785751, "payoutRatio": 0.3574397339983375, "dividendPerShare": 3.54, "dividendYearsRising": 0, "dividendCut": false, "note": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown." }, "peers": { "sic": 6324, "sicDescription": "Hospital & Medical Service Plans", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "6324", "growth": [ 0.1222, 10 ], "opMargin": [ 0.0134, 10 ], "equityRatio": [ 0.2641, 9 ], "returnOnEquity": [ 0.0506, 9 ] }, "credibility": { "auditedYears": 5, "weight": "reasonable", "standard": "ASOP No. 25", "nonReliance": null, "auditorChange": null }, "healthWatch": { "window": "last 12 months", "since": "2025-09-26", "signals": [ { "code": "5.02", "label": "Director or officer change", "count": 3, "latest": { "filed": "2026-07-29", "url": "https://www.sec.gov/Archives/edgar/data/49071/000004907126000047/0000049071-26-000047-index.htm" } } ], "note": "Events the company itself filed with the SEC, most serious first. Shown beside the figures; they do not change the range or its receipt." }, "range": { "low": 130290414003.33215, "high": 148739962564.69647, "baseline": 143846022095.73215, "coverage": 0.8, "method": "v4.1", "basis": "next fiscal year revenue: baseline = revenue x (1 + mean of one-year and three-year pace); width = the company's own volatility of yearly growth, credibility-weighted against its size class (Buhlmann), scaled to the 80% target on 2023 and tested on 2024", "calibratedOn": { "companyYears": 1471, "sizeBand": "$10B+", "fitYears": [ 2018, 2022 ], "tuneYear": 2023, "testYear": 2024, "coverageOnTestYear": 0.8341 }, "credibility": { "weightOnOwnRecord": 0.5, "growthYears": 4, "ownVolatility": 0.01747334717722121, "classVolatility": 0.06659579566308972, "pricedVolatility": 0.048684278065797094, "k": 3 }, "stress": { "low": 122926865959.87189, "high": 156846482793.3808, "basis": "the same range with widths set to hold 80% across 2018-2023, pandemic years included" }, "kind": "a statistical range, not company guidance; no view on the share price", "track": { "backtest": { "tests": 15, "hits": 11, "rate": 0.7333333333333333, "method": "v4", "byYear": { "2011": [ 1, 1 ], "2012": [ 1, 1 ], "2013": [ 1, 1 ], "2014": [ 0, 1 ], "2015": [ 1, 1 ], "2016": [ 0, 1 ], "2017": [ 1, 1 ], "2018": [ 1, 1 ], "2019": [ 0, 1 ], "2020": [ 0, 1 ], "2021": [ 1, 1 ], "2022": [ 1, 1 ], "2023": [ 1, 1 ], "2024": [ 1, 1 ], "2025": [ 1, 1 ] }, "note": "hindsight: the same credibility-weighted range on the company's own past years. Years 2018-2023 were used to fit or tune the method, so only 2025 outcomes are fully out of sample." }, "registry": { "logged": "2026-09-26T16:33:40.867Z", "hash": "0b4576feb331bea6", "status": "open" }, "scorecard": "https://www.pops4.com/boards/scorecard" } }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000049071.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=49071" }, "speedCash": { "fiscalYear": 2025, "cashConversion": 0.0071, "growth3y": 0.1177, "volatility": 0.0175, "paysDividend": true, "raisedDividend": false, "equityRatio": 0.361, "quadrant": { "code": "fs", "label": "Fast and steady", "plain": "growing faster than its size class, with steadier revenue" }, "compass": { "code": "notyet", "inside": "Turns 0.7% of revenue into operating cash; revenue growing 11.8% a year over three years; pays a dividend.", "outside": "Among $10B+ companies: 5th percentile for cash, 83rd for growth.", "emoji": "⚡", "label": "Fast, cash not yet", "plain": "growing fast, but little cash arriving so far" }, "band": "$10B+", "cashPctInClass": 5, "growthPctInClass": 83, "source": "SEC XBRL frames, the company’s own audited figures; quadrant split at the median of its size class" }, "harbor": { "signs": [], "rule": "Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider.", "level": 0, "name": "New ship", "plain": "no warning signs" }, "cashFlow": { "fiscalYearEnd": "2025-12-31", "operating": 921000000, "investing": 2273000000, "financing": -1215000000, "capitalSpending": 546000000, "free": 375000000, "trend": [ { "fiscalYearEnd": "2021-12-31", "operating": 2262000000, "free": 920000000 }, { "fiscalYearEnd": "2022-12-31", "operating": 4587000000, "free": 3450000000 }, { "fiscalYearEnd": "2023-12-31", "operating": 3981000000, "free": 2977000000 }, { "fiscalYearEnd": "2024-12-31", "operating": 2966000000, "free": 2391000000 }, { "fiscalYearEnd": "2025-12-31", "operating": 921000000, "free": 375000000 } ], "note": "Annual, as filed in 10-K cash flow statements; negative investing/financing = cash going out (capital spending, buybacks, dividends, debt repaid)." }, "investments": { "fiscalYearEnd": "2025-12-31", "cash": 4200000000, "shortTerm": 999000000, "longTerm": 15197000000, "equityHoldings": null, "totalAssets": 48909000000, "ladder": { "within1y": 999000000, "y1to5": 4327000000, "y5to10": 3921000000, "y10plus": 1115000000, "noSingleDate": 5834000000 }, "currentRatio": 2, "unrealizedGain": 46000000, "unrealizedLoss": 867000000, "note": "Balance-sheet cash and investment securities at fiscal year end, as filed; short-term = due or saleable within a year. Insurers and banks hold most of their book here." } }, "definitions": { "operatingMargin": "Operating income divided by revenue.", "netMargin": "Net income divided by revenue.", "freeCashFlow": "Cash from operations minus spending on property and equipment.", "researchShareOfRevenue": "Research and development expense for the year as a share of revenue, both as filed.", "equityRatio": "Shareholders equity as a share of total assets, both as filed. Higher means less of the company is owed to someone else.", "returnOnEquity": "Net income for the year against shareholders equity at year end.", "payoutRatio": "Dividends paid as a share of net income, in the year the cash went out.", "dividendYearsRising": "Consecutive years, counted back from the last on record, in which dividend per share rose. A fall ends the run and is reported as dividendCut.", "revenueGrowthPerYear": "Compound annual growth between the first and latest fiscal years shown.", "credibility": "How much weight a record deserves, in the actuarial sense (ASOP No. 25): more audited years, more weight.", "peers": "Medians of SEC filers with $50M+ revenue in the same industry code (SIC), narrowest group with at least 8 filers, calendar-year figures from SEC XBRL frames.", "backtest": "The same range method applied to the company's own past years, scored against what it actually reported next. Hindsight, and labelled so.", "healthWatch": "Distress-type events the company filed in the last 12 months (late-filing notices; 8-K items 1.03, 3.01, 2.04, 4.02, 4.01, 2.05, 2.06, 1.05, 5.02), each with its count and newest filing. Display only: they do not change the range or its receipt." }, "speedCash": { "fiscalYear": 2025, "cashConversion": 0.0071, "growth3y": 0.1177, "volatility": 0.0175, "paysDividend": true, "raisedDividend": false, "equityRatio": 0.361, "quadrant": { "code": "fs", "label": "Fast and steady", "plain": "growing faster than its size class, with steadier revenue" }, "compass": { "code": "notyet", "inside": "Turns 0.7% of revenue into operating cash; revenue growing 11.8% a year over three years; pays a dividend.", "outside": "Among $10B+ companies: 5th percentile for cash, 83rd for growth.", "emoji": "⚡", "label": "Fast, cash not yet", "plain": "growing fast, but little cash arriving so far" }, "band": "$10B+", "cashPctInClass": 5, "growthPctInClass": 83, "source": "SEC XBRL frames, the company’s own audited figures; quadrant split at the median of its size class" }, "harbor": { "signs": [], "rule": "Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider.", "level": 0, "name": "New ship", "plain": "no warning signs" }, "cashFlow": { "fiscalYearEnd": "2025-12-31", "operating": 921000000, "investing": 2273000000, "financing": -1215000000, "capitalSpending": 546000000, "free": 375000000, "trend": [ { "fiscalYearEnd": "2021-12-31", "operating": 2262000000, "free": 920000000 }, { "fiscalYearEnd": "2022-12-31", "operating": 4587000000, "free": 3450000000 }, { "fiscalYearEnd": "2023-12-31", "operating": 3981000000, "free": 2977000000 }, { "fiscalYearEnd": "2024-12-31", "operating": 2966000000, "free": 2391000000 }, { "fiscalYearEnd": "2025-12-31", "operating": 921000000, "free": 375000000 } ], "note": "Annual, as filed in 10-K cash flow statements; negative investing/financing = cash going out (capital spending, buybacks, dividends, debt repaid)." }, "investments": { "fiscalYearEnd": "2025-12-31", "cash": 4200000000, "shortTerm": 999000000, "longTerm": 15197000000, "equityHoldings": null, "totalAssets": 48909000000, "ladder": { "within1y": 999000000, "y1to5": 4327000000, "y5to10": 3921000000, "y10plus": 1115000000, "noSingleDate": 5834000000 }, "currentRatio": 2, "unrealizedGain": 46000000, "unrealizedLoss": 867000000, "note": "Balance-sheet cash and investment securities at fiscal year end, as filed; short-term = due or saleable within a year. Insurers and banks hold most of their book here." } }